These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 29138084

  • 21. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, Soares IS, Costa FT, Rodrigues MM.
    Vaccine; 2010 Apr 01; 28(16):2818-26. PubMed ID: 20170765
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct 01; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 23. F18+Escherichia coli flagellin expression in Salmonella has immunoadjuvant effects in a ghost vaccine candidate containing E. coli Stx2eB, FedF and FedA against porcine edema disease.
    Won G, Lee JH.
    Comp Immunol Microbiol Infect Dis; 2018 Jun 01; 58():44-51. PubMed ID: 30245050
    [Abstract] [Full Text] [Related]

  • 24. Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.
    Song L, Xiong D, Hu M, Kang X, Pan Z, Jiao X.
    BMC Vet Res; 2017 Jun 21; 13(1):190. PubMed ID: 28637471
    [Abstract] [Full Text] [Related]

  • 25. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Lai CH, Tang N, Jan JT, Huang MH, Lu CY, Chiang BL, Huang LM, Wu SC.
    Vaccine; 2015 Aug 20; 33(35):4321-9. PubMed ID: 25858857
    [Abstract] [Full Text] [Related]

  • 26. Vaccines in prophylaxis of urinary tract infections caused by the bacteria from the genus Proteus.
    Drzewiecka D, Lewandowska G.
    Postepy Hig Med Dosw (Online); 2016 Sep 30; 70(0):1032-1043. PubMed ID: 27708208
    [Abstract] [Full Text] [Related]

  • 27. Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18+Escherichia coli.
    Won G, Lee JH.
    Vaccine; 2016 Dec 07; 34(50):6335-6342. PubMed ID: 27817960
    [Abstract] [Full Text] [Related]

  • 28. Salmonella enterica serovar Enteritidis ghosts displaying a surface FliC adjuvant elicit a robust immune response and effective protection against virulent challenge.
    Senevirathne A, Hewawaduge C, Lee JH.
    Vet Microbiol; 2020 Apr 07; 243():108633. PubMed ID: 32273012
    [Abstract] [Full Text] [Related]

  • 29. In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infections.
    Habibi M, Asadi Karam MR, Bouzari S.
    Adv Biomed Res; 2015 Apr 07; 4():217. PubMed ID: 26605246
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F, Shaffifar M, Farahmand B, Shirian S, Saeidi M, Tabarraei A, Gorji A, Ghaemi A.
    Arch Virol; 2017 May 07; 162(5):1251-1260. PubMed ID: 28120096
    [Abstract] [Full Text] [Related]

  • 31. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P.
    Pathog Dis; 2013 Mar 07; 67(2):104-7. PubMed ID: 23620155
    [Abstract] [Full Text] [Related]

  • 32. Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.
    Verma SK, Gupta A, Batra L, Tuteja U.
    Vaccine; 2019 Jan 03; 37(1):19-24. PubMed ID: 30497835
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein.
    Schuster O, Sears KT, Ramachandran G, Fuche FJ, Curtis B, Tennant SM, Simon R.
    Hum Vaccin Immunother; 2019 Jan 03; 15(6):1436-1444. PubMed ID: 29873578
    [Abstract] [Full Text] [Related]

  • 38. Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens.
    Asadi Karam MR, Habibi M, Bouzari S.
    Biologicals; 2016 Sep 03; 44(5):378-86. PubMed ID: 27461240
    [Abstract] [Full Text] [Related]

  • 39. MrpH, a new class of metal-binding adhesin, requires zinc to mediate biofilm formation.
    Jiang W, Ubhayasekera W, Breed MC, Norsworthy AN, Serr N, Mobley HLT, Pearson MM, Knight SD.
    PLoS Pathog; 2020 Aug 03; 16(8):e1008707. PubMed ID: 32780778
    [Abstract] [Full Text] [Related]

  • 40. Vaccination to Protect Against Proteus mirabilis Challenge Utilizing the Ascending Model of Urinary Tract Infection.
    Smith SN, Himpsl SD, Mobley HLT.
    Methods Mol Biol; 2019 Aug 03; 2021():201-215. PubMed ID: 31309507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.